July 7, 2022 by Chain Drug Review
Biden administration, JC Scott, PCMA
Leading Headlines, Pharmacy

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on the Biden Administration’s announcement to curb drug manufacturer patent abuses. “We applaud the Biden Administration for taking real action to reduce prescription drug costs. Drug manufacturer pricing strategies that include patent thickets on certain brand drugs unfairly protect
March 9, 2022 by Chain Drug Review
American Society of Health-System Pharmacists, Biden administration
Leading Headlines, Pharmacy

BETHESDA, Md. — Today, 14 pharmacy organizations urged the Biden administration to remove barriers preventing pharmacists from ordering oral antivirals and expand patient access to the “Test to Treat” initiative announced last week during the State of the Union. to President Biden, the groups called for the removal of a limitation placed on the emergency
January 7, 2022 by Chain Drug Review
Biden administration, DIR fees, NACDS
Featured Articles, Leading Headlines, Pharmacy

ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) on Friday lauded the Biden Administration for initiating action to rein in direct and indirect remuneration (DIR) fees and pledged continued vigilance to optimize the regulatory proposal for the benefit of seniors and for the viability of the pharmacies that serve them. “DIR fees
November 22, 2021 by Jeffrey Woldt
Biden administration, vaccine mandate
November 22, 2021, Opinion

Like many other policies intended to curb the spread of COVID-19, the Biden administration’s emergency temporary standard (ETS), which requires companies with 100 or more employees to ensure that members of their workforce are immunized or undergo weekly testing, has become a flashpoint. In addition to expected resistance from many Republicans, some business groups, including
September 10, 2021 by Chain Drug Review
Biden administration, COVID-19, FMI
Leading Headlines, Pharmacy

ARLINGTON, Va. — The Biden administration’s announcement of vaccine mandates for businesses raises serious questions for retailers and supplier companies, two trade associations said on Friday. “The announcement yesterday by President Biden of an employer mandate on vaccinations and testing for employees, including fines and penalties for businesses that fail to comply, raises a tremendous
September 9, 2021 by Chain Drug Review
Biden administration, NCPA
Leading Headlines, Pharmacy

ALEXANDRIA, Va. — The National Community Pharmacists Association issued the following statement today on behalf of CEO B. Douglas Hoey in response to President Biden’s “Path out of the Pandemic” plan: “Community pharmacy has been on the front lines of the fight against COVID-19 since the start of the pandemic. Local pharmacies have administered tens of
September 9, 2021 by Chain Drug Review
Biden administration, COVID-19
Leading Headlines, Pharmacy

WASHINGTON — President Biden today unveiled an new six-part plan to combat COVID-19 as the highly transmissible Delta variant spreads and some 80 million eligible Americans remain unvaccinated. “We’ve been patient, but our patience is wearing thin,” he said in a speech from the White House, making clear that he blamed the unvaccinated for the
August 17, 2021 by Chain Drug Review
Biden administration, COVID-19 booster shot
Leading Headlines, Pharmacy

WASHINGTON — The Biden administration announced that Americans who have been fully vaccinated against COVID-19 should receive a booster shot to ensure continued protection, according published reports. The plan, which is still being developed, would involve administering third shots beginning in mid- to late September, one source added, pending authorization from the US Food and
August 9, 2021 by Jeffrey Woldt
Biden administration, Jeffrey Woldt editor-in-chief Chain Drug Review
August 9, 2021, Opinion

President Biden last month signed an executive order intended to limit the clout of big business and enhance competitive prospects for small and mid-sized companies. The sweeping document — which includes 72 specific elements, among them provisions instructing the Food and Drug Administration to clear the way for prescription drug imports from Canada (a very
February 16, 2021 by Chain Drug Review
Biden administration, COVID-19 vaccines
Pharmacy

WASHINGTON — According to published reports, White House press secretary Jen Psaki said Tuesday that the Biden administration will be increasing weekly shipments of COVID-19 vaccine doses to states, sending out 13.5 million this week, and doubling the amount going to retail pharmacies. As of last week, the administration was shipping out 11 million doses
February 8, 2021 by Jeffrey Woldt
Biden administration, Chain Drug Review's Video Forum, NACDS, Steve Anderson
Featured Articles, Leading Headlines, Pharmacy, Videos

With the Biden administration and the 117th Congress in place, we asked Steve Anderson, president and chief executive officer of the National Association of Chain Drug Stores, to share his thoughts about the current state of the nation’s government and politics, and what it means for retail pharmacy. Implications of last month’s riot on
February 2, 2021 by Chain Drug Review
B. Douglas Hoey is the chief executive officer at the National Community Pharmacists Association., Biden administration, COVID-19 vaccines in pharmacies, The National Community Pharmacists Association
Leading Headlines, Pharmacy

ALEXANDRIA, Va. — The National Community Pharmacists Association released the following statement from CEO B. Douglas Hoey, in response to the Biden administration’s plans to ship coronavirus vaccine doses directly to select pharmacies across the country: “When independent pharmacies have access to the vaccine, they are able to quickly get the coronavirus shots in patients’ arms.
February 2, 2021 by Chain Drug Review
Biden administration, COVID-19 vaccines in pharmacies, NACDS, NACDS president and chief executive officer Steven Anderson
Leading Headlines, Pharmacy

ARLINGTON, Va. – National Association of Chain Drug Stores (NACDS) President and CEO Steven Anderson issued the following statement following the Biden Administration’s launch today of the Federal Pharmacy Partnership Program, as described by White House COVID-19 Response Coordinator Jeff Zients: “Today’s announcement is another crucial step forward to helping Americans get back to all